(LNSR - LENSAR INC)

company profile

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System. The company offers LENSAR Laser System which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

Lensar (LNSR) is trading at 5.38

Open Price
5.38
Previous close
5.385
Previous close
5.385
P/E Ratio
0
Sector
Health Care
Shares outstanding
12104328
Index
R2000,R3000
Primary exchange
NASDAQ-NMS
ISIN
US52634L1089